InveniAI and Kyowa Kirin Enter AI-Powered Novel Target Discovery Collaboration

NEXT STORY
Applied Therapeutics Announces Launch of Galactosemia Awareness and Education Initiative
PREV STORY
ERYTECH annuncia i risultati positivi dello studio di Fase II su eryaspase per il trattamento della leucemia linfoblastica acuta, presentati in occasione del convegno annuale dell’American Society of Hematology
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CRISPR Technology Market to Grow by 20.91% in 2020, Accelerated by the Outbreak of COVID-19 – Industry Projections to 2030

author_avatar
NASDAQ Market News

Dr. William Chey Highlights Unmet Medical Need of Lactose Intolerance and Potential for Phase 3 Drug Candidate RP-G28 in Expert Call Hosted by Ritter Pharmaceuticals

author_avatar
NASDAQ Market News

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE “TRANSPARENCY LAW”)

REGULATED INFORMATION GHENT, Belgium, 29 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] ...

author_avatar
NASDAQ Market News